News

AstraZeneca sells stake in Moderna for more than $1 billion

AstraZeneca has sold its 7.7% stake in Moderna for more than $1 billion, after the latter’s shares surged following its launch of a coronavirus vaccine. The report added that the period during which British company AstraZeneca sold its stake in US Moderna is unknown, and the two companies did not immediately respond when asked for comment.

The report stated that AstraZeneca will maintain its partnership with Moderna in developing drugs and other treatments but may sell its coronavirus vaccine, which it developed in partnership with Oxford University, as a commercial product in the future if the virus becomes endemic.

It is worth noting that Moderna, whose vaccine has obtained a license for emergency use against the Corona virus in the United States, said last week that sales of its vaccine this year may reach $ 18.4 billion, according to the company’s expectations.

Related Articles

Back to top button